Mitraloza

Mitraloza is a medication used to treat high blood pressure, specifically in patients with left ventricular hypertrophy (LVH) or left ventricular dysfunction. It is a combination of two active ingredients: amlodipine, a calcium channel blocker, and olmesartan, an angiotensin II receptor antagonist. The drug works by relaxing blood vessels and reducing the workload on the heart, thereby lowering blood pressure.

Mitraloza is available in tablet form and is typically taken once daily. It is generally well-tolerated, but like any medication, it can cause side effects. Common side effects include dizziness, headache, and fatigue. More serious side effects, such as swelling of the ankles or feet, are less common but can occur.

The medication is indicated for adults with systolic blood pressure of 160/100 mmHg or higher, or a diastolic blood pressure of 100 mmHg or higher, in the presence of LVH or left ventricular dysfunction. It is important to note that mitraloza should not be used in patients with severe renal impairment or those who are pregnant or breastfeeding.

Mitraloza was approved by the U.S. Food and Drug Administration (FDA) in 2019. It is marketed under the brand name Mitravon. The drug is manufactured by Teva Pharmaceutical Industries Limited. As with any medication, patients should consult their healthcare provider before starting mitraloza to discuss potential benefits and risks.